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Barry and Goebel (1, 2) first described a sialic acid polymer from bacteria, which 
they called colominic acid, in an Escherichia  coli,  strain K235. Later, this sialic acid 
polymer was shown to be the K1  capsular polysaccharide of E.  coli (2-9).  There is 
much evidence that the K1 capsular polysaccharide confers invasiveness to E. coli (9- 
18). Among the serologically defined E. coli surface antigens, there are, to date, 164 O 
(lipopolysaccharide), 56 H  (flagellar), and  103 K  (envelope or capsular) antigens (8, 
11,  19-21).  In surveys of E.  coli CSF isolates from newborns, ~  80% were K1 strains 
(10,  12, 13, 22). K1 strains comprised ~  50% of blood isolates from newborns without 
meningitis and 50% of upper urinary tract infections of infants (10,  12,  16,  17, 23). 
There were no associations with other E. coli K, O, or H  antigens or biotypes among 
these  disease  isolates  (10,  12,  13,  22,  24).  Further  evidence  is  derived  from  the 
protective effect of K1 antibodies in laboratory animals (9,  10,  13, 25).  In an infant 
rat  model,  K1  strains,  in  contrast  to  E.  coli  with  other  capsular  polysaccharides, 
induced bacteremia and meningitis after intestinal colonization (14). Passive admin- 
istration of anti-K1  antibody protected against bacteremia and death but did not 
affect intestinal colonization in Kl-fed infant rats (25). 
Both the E. coli K 1 and Group B meningococcal capsular polysaccharides consist of 
linear homopolymers of a  2-8-1inked  N-acetyl neuraminic acid  (NANA) 1 (1-4,  26, 
27).  No antigenic differences were detected by double immunodiffusion of K1  and 
group B meningococcal polysaccharides with group B meningococcal and E. colt" K1 
antisera (10, 28, 29). In contrast to most encapsulated bacteria, K1 capsules are poor 
immunogens when injected intravenously as formalin-inactivated organisms in labo- 
ratory animals and as purified polysaccharides in most adult volunteers (8, 11, 20, 28, 
29, 30).  However, repeated intravenous injections of formalinized group B meningo- 
coccus organisms, strain B-11, into a horse (No. 46), yielded high-titered anticapsular 
antiserum  used  to  identify both  group  B  meningococci and  E.  coli  K1  strains  by 
precipitin formation (halos) in agar and by immunoelectrophoresis of whole organism 
extracts (10,  12, 14, 17). 
It was observed that sera, produced at different times with living cultures of the test 
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strain  K1  (U5/41  =  OI:KI:H-),  varied  in  their  ability  to agglutinate  that  same 
strain  (1 I,  21).  It was  further  observed  that  K1  colonies could be divided  into  two 
types based upon their ability to give weak or strong agglutinates with rabbit typing 
antisera.  Reculture of strongly agglutinating colonies, originally designated  K1 posi- 
tive,  regularly  gave rise  to many strongly agglutinating  colonies and  a  few weakly 
agglutinating colonies (K1  negative)  with a  ratio of ~  20-50/1.  Upon reculture,  the 
weakly agglutinating colonies (K1  negative)  mostly gave rise at about the same ratio 
of 20-50/1.  The Kl-negative colonies were only weakly immunogenic when injected 
into rabbits. In contrast, the strongly agglutinating colonies induced K1 antibodies in 
a large proportion of rabbits. When this phenomenon was examined by the antiserum 
agar technique, using the horse 46 group B meningococcal antiserum, the Kl-positive 
colonies gave only faint halos in contrast to the dense precipitin halos yielded by the 
Kl-negative  colonies.  Both  K1  types  agglutinated  with  group  B  meningococcal 
antiserum  although the Kl-negative organisms gave the strongest  agglutinates.  The 
group  B  meningococcal  antiserum  agar  was  thus  advantageous  for  study  of the 
reversion phenomenon. 
This frequent change in Kl-capsular polysaccharide phenotypes, first described by 
Orskov et al.  (11, 32), has been designated  form variation because of its similarity to 
antigenic  variation  in  Salmonella  0  antigens  (19,  31).  Interest  in  Kl-form  variation 
was heightened  by our studies of neonatal Escherichia  coli Kl-disease  isolates because 
90% were of the Kl-negative colonial type (10,  12). 
Materials  and Methods 
Bacterial  Strains.  To  facilitate  their  description  and  to  avoid  confusion  among other  K 
antigens, the designation OAe +  (O-acetyl positive)  and OAe- (O-acetyl negative) will be used 
for the form variants previously described as K1 positive and K1 negative, respectively. E. coli 
strains, C94 (O7:KI:H-), LH (O75:Kl:H3), and EC3 (O1 :KI:H-) were disease  isolates  (12, 
14). Strains D698 OAc +  and D699 OAc- (originally designated K1 + and KI-, respectively), 
were derived from one parent strain (U5/41  =  OI:KI:H7). The strain labeled O16 is the test 
strain for O antigen  16 (F11119/41  =  O16:KI:H-) (20, 31). This strain is stable in the OAc- 
form. Strain C375 (O132:K1 :H-), is a disease isolate from a newborn with meningitis (12). Dr. 
Walter Goebel, The Rockefeller University, N.Y., provided E. coli strain K235 (O1 :K1 :H-) (1, 
2). The E. coli strain (O7:KI:H,-) studied by Grados and Ewing (28) and later by Kasper et 
al.  (29), was kindly donated by Ms. Brenda Brandt, Walter Reed Army Institute of Research. 
The organisms were stored as freeze-dried 10% skimmed milk suspensions. 
Analytical  Methods.  Sialic  acid  was  determined  by the  methods  of Svennerholm  and/or 
Warren, using NANA (Sigma Chemical Co., St.  Louis, Mo.), as a reference standard (36, 37). 
The  effect  of neuraminidase  treatment  was  determined  using  influenza  virus  A2/Victoria 
(Parke Davis & Co., Detroit, MI, lot Rx9120, CCA content  15215 U/ml)  and neuraminidase 
(purified enzyme type V)  from Clostridium  perfringens  (Sigma Chemical Co.)  (38). Protein was 
determined by the method of Lowry (39) using bovine serum albumin as a standard.  Nucleic 
acid  was  determined  by  the  absorption  of a  1.0  mg/ml  solution  at  260  nm  assuming  an 
extinction coefficient of 20.0. O-acetyl was determined by the colorimeteric method of Hestrin 
(40). Moisture content was determined at 100 ° C by thermal gravimetric analysis and all values 
were expressed as dry weight (41). Lipolysaccharide (LPS or O antigen) was assayed by Limulus 
polyphemus  amebocyte lysate gelation (LAL, Associates of Cape Cod, Woods Hole, Mass.  and E. 
coli endotoxin lot EC2, Bureau of Biologics,  Food and Drug Administration)  (42). 
Polysaccharides.  E. coli were cultivated in modified Frantz medium utilizing 5% sodium beta 
glycerol phosphate as a carbon source and 0.1% sterile-filtered  yeast dialysate (43, 44). When 
the bacteria  ceased to multiply  logarithmically, an equal  volume of 0.2% Cetavlon  (Sigma 
Chemical Co.), was added to the culture and the resultant  precipitate harvested by centrifu- 
gation. The polysaccharide was isolated by dissociation in 1.0 M CaCI2, sequential precipitation ORSKOV  ET  AL.  671 
of nucleic acids and K1 polysaccharide with ethanol, removal of residual protein by cold phenol 
extraction and  sedimentation of LPS  by ultracentrifugation  (43).  The  resultant  supernate, 
containing  K1  polysaccharide, was  dialyzed  extensively  against  deionized  water  at  4°C, 
lyophilized, and stored at -30°C. Group B meningococcal capsular polysaccharide, lot FRII, 
was generously donated by Dr. Emil C. Gotschlich, The Rockefeller University. 
De-O-Acetylation.  The K10Ae + variant D698 polysaecharide, 100 rag, was dissolved in 50 
ml of 0.1  N  NaOH.  After heating at  37°C  for 4 h, the material was neutralized with HC1, 
lyophilized, dialyzed against water at 4°C, and relyophilized to yield ca 60 mg. 
Nuclear Magnetic Resonance Spectroscopy (NMR).  13C  natural abundance NMR  spectra were 
determined at 24.05  MHz  (JEOL FX-100 spectrometer) and 67.89 MHz  (homebuilt system) 
(33). Both spectrometers were equipped with quadrature phase detection. Samples were run at 
pH  7.0,  =* 20°C  at concentrations of ~- 50  mg/ml.  Spectral parameters were as follows: At 
24.05  MHz, 12 ~  (90 °) pulse, 2.5 s pulse repetition time, 5 kHz spectral window with matched 
filter, 8 K  data points with 8 points zero filling; at 67.89 MHz, 29/as (90 °) pulse, 2.5 s pulse 
repetition. 16 kHz spectral window with 20 kHz filter, 16 K  data points with 16 K  points zero 
filling. Before  Fourier transformation,  the  free  induction  decay signals were  exponentially 
multiplied to  produce  a  2.0  Hz  additional  line  broadening.  Broad  band  decoupling was 
employed in all cases, but gated to suppress the nuclear Overhauser effect enhancement for O- 
acetyl analysis (34, 35). 
Gel Filtration.  The molecular size of the K 1 polysaccharides was estimated by calculation of 
the  Kd  (partition coefficient)  after  gel  filtration  through  Sepharose  4B  (Pharmacia  Fine 
Chemicals, Div. of Pharmacia Inc., Piscataway, N. J., lot 3325) using 0.2 M ammonium acetate 
as eluent. The columns were calibrated by Blue Dextran (Pharmacia Fine Chemicals, Div. of 
Pharmacia, Inc.) and [a4C]sodium acetate (Amersham Corp., Arlington Heights, Ill.) (41, 44). 
Serological Methods.  Antiserum agar was prepared with 10% horse 46 group B meningococcal 
antiserum in  1.0% agarose (Sigma Chemical Co.) and Davis Minimal Medium (Difco Labo- 
ratories,  Detroit,  Mich.)  (14,  15,  45,  46).  Halos  were  observed  around  the  colonies after 
incubation at 37°C from 18 to 24 h and then for 4-8 h in a refrigerator. Immunodiffusion was 
performed  in  0.9%  agarose  in  phosphate-buffered  saline  (PBS),  pH  7.4.  Countercurrent 
immunoelectrophoresis (CIE), and qualitative and quantitative immunoelectrophoresis (IEP) 
were performed using horse 46 group B meningoeoecal and rabbit E. coli antisera (20, 47-51). 
Quantitative Precipitin Analysis.  Horse 46 serum was brought to 37% saturation with ammo- 
nium sulfate at 4°C and the resultant precipitate removed by centrifugation at  14,000 g, 4°C 
for  2  h.  The  supernate  was  brought  to  55%  saturation  with  ammonium  sulfate  and  the 
precipitate collected by centrifugation at  14,000 g, 4°C for 2 h, dialyzed extensively against 
0.15 M  NaCI, sterile filtered through a 0.4 #m membrane (Nalge, Rochester, N. Y.) and stored 
at  -20°C.  Equal volumes (1.0 ml)  of K1  polysaccharides from strains D698  (OAc+), D699 
(OAc-), or O16  (OAc-) and the globulin were mixed and incubated at 37°C for 1 h and 3 d 
at 4°C. The precipitates were isolated by centrifugation and washed three times with saline at 
4°C  (52).  The  precipitates were  dissolved in  5.0  ml  of 0.8%  sodium lauryl sulfate and  the 
antibody content calculated by assuming an extinction coefficient of 14.0 at 280 nm. Antigen 
and antibody remaining in the supernates were detected by CIE (47). 
Comparative Immunogenicity.  Rabbits and two burros were injected intravenously with for- 
malinized organisms taken from an exponentially growing culture (19, 21). Their preimmune 
sera showed no precipitins with either Kl-variant polysaccharides. The animals were bled 4-6 
d after the last intravenous injection and their sera separated under sterile conditions and stored 
at -20°C. Their Kl-antibody content was estimated by CIE using an endpoint titration with 
dilutions  of the  antisera  reacting  with  group  B  meningococeal  (OAt-)  or  D698  (OAc  +) 
polysaccharides. 
Results 
Characterization  of K1-Form  Variation.  Several serologically defined E. coli K1 strains 
yielded a proportion of colonies weakly agglutinated with World Health Organization 
(WHO) rabbit typing antisera. This lesser agglutinability of daughter colonies ranged 
from  1/20  to  50  colonies and  was  constant  for  a  given strain.  Cultivation of these 
weakly agglutinating colonies revealed a  similar low reversion to a  stronger aggluti- 672  ESCHERICHIA COLI K1-POLYSACCHARIDE FORM VARIATION 
nation  reaction.  When  grown  on  group  B  meningococcal antiserum  agar,  strains 
weakly agglutinating with rabbit  Kl-typing antisera yielded a  majority of colonies 
with dense halos. When a  faintly haloed colony was subcultured, it was found that 
most of the daughter colonies yielded the faint halo type and were strongly agglutin- 
able in the WHO rabbit  K1  typing antisera. Similar results for changes in colony 
phenotype were obtained for the weakly agglutinated densely haloed colonies. The 
WHO rabbit K1 typing antisera were produced with E. coll' D698, a strain mostly in 
the OAc+  form.  It was  not  possible  to  illustrate  this  difference in  halo intensity 
between the variants by photographs, accordingly an artist's touch up of the originals 
is shown in Fig. 1. Strain D699, derived from the same E. coli parent as D698 yielded 
mostly colonies with dense halos (Table I). The strain O16 yielded only dense halos 
even  after repeated  dilution  and  transfer of single colonies.  Upon  initial  culture, 
strains C94,  LH, and EC3 yielded mostly densely haloed colonies. These three K1 
strains  behaved  similarly to  D698/D699  as  subcultures  of single  variant  colonies 
produced cultures with a  predominance of one halo type. These variants had  the 
same O  and H  antigens as their parent.  The reversion rates of these form variant 
pairs is shown in Table I. The WHO O16 test strain, O16:K1:H- (Flll 19/41)  and 
strain K235  (OI:KI:H-)  yielded only densely haloed colonies. Grados and Ewing 
strain  O7:KI:H-,  used  for preparation  of K1  capsular  polysaccharide vaccine in 
human volunteer studies, yielded mostly densely haloed colonies (OAc-). Strain C375 
yielded only faintly haloed colonies (OAc +). 
Polysaccharides.  Table II shows the chemical composition and characteristics of K1 
polysaccharides from variant pairs derived from the same parent. All K1 preparations 
were  composed  of sialic  acid  with  only  traces  of protein  and  nucleic  acid.  The 
molecular  sizing  characteristics,  as  determined  by  Kd.  values  were  similar.  The 
endotoxin content of the polysaccharides, used as an estimate of O-antigen contami- 
nation, ranged from 2.5% for D698 and 0.25%  for D699 to <0.1% for the other K1 
and group B meningococcal polysaccharides. The only detectable difference among 
these  preparations  was  their  O-acetyl  content.  K1  polysaccharide,  derived  from 
strongly agglutinable faint-haloed colonies, had O-acetyl values ranging from 2.5 to 
4.3 #mol/mg as determined by the Hestrin method and from 0.2 to 0.85 O-acetyl eq/ 
NANA as determined by lag NMR. K1 polysaccharide extracted from strain C375 
that yielded only faint haloes had an O-acetyl content of 2.5 #M/mg by the Hestrin 
method and 0.22 O-acetyl equivalents/NANA residue. K1  polysaccharides derived 
from poorly agglutinated densely haloed colonial variants had little or no detectable 
O-acetyl. The K1  preparation  from the O16 strain, stable in the OAc-  form, and 
group  B  meningococcal  polysaccharide  had  no  detectable  O-acetyl  (20,  27).  K1 
polysaccharides extracted from E. coli strains K235 and O7:KI:NM (26, 27) had no 
detectable O-acetyl. 
lSC  Nuclear  Magnetic  Resonance  Spectroscopy.  The  natural  abundance  laC  NMR 
spectrum of the K1 OAc- variant polysaccharide is identical to that of the group B 
meningococcal  polysaccharide  (Fig.  2).  Its  composition  and  linkage  is,  therefore, 
confirmed as an a-2-8 homopolymer of sialic acid (3, 4, 26,  27, 53).  The laC-NMR 
spectrum  on  the  K10Ac + variant  exhibited  a  relatively more complex spectrum, 
similar to the naturally occurring pseudo-randomly O-acetylated group C  meningo- 
coccal polysaccharides (26, 54). A resonance attributable to the OC(O)CHa carbon in 
the K 1-positive variant was observed at ~ 1.5 ppm to higher field of the NHC (O)CHa ~RSKOV  ET  AL.  673 
FIG.  1.  Halo precipitin formation of E.  coli K1  strains cultivated on horse 46 group B meningo- 
coccal  antiserum agar.  E.  coli strain D698  (OAc+)  on the left and D699  (OAe-)  on the right 
derived from the same parent, (U5/41  ~  OhKhH7), were grown for 18 h at 37°C and incubated 
at 8 h  in a  refrigerator. Representative colonies indicating the majority faint haloed from variant 
D698 (OAe+) and dense haloed D699 (OAe-) are shown. The halos are touched up by an artist 
because it was not possible to illustrate this difference with direct photographs. 
TABLE  I 
Rate of Form  Variation among Escherichia coli K1  Strains 
E. colt' strain  Reversion rate  No. of colonies ex- 
amined 
D699 K 10Ac-  1/30  5,500 
D698 K10Ac+  1/30  5,500 
C94 K10Ac-  1/40  2,847 
C94 K10Ac+  1/50  4,886 
LH KI OAc-  1/40  413 
LH KI OAc+  1/40  596 
O16 K10Ac-  None detected  5,000 
(2375 KI OAc +  None detected  5,000 
Single colonies were identified for their variant status by halo formation on 
horse 46  group  B  meningococcal antiserum agar.  These colonies were  sus- 
pended in saline, replated on antiserum agar, and halo formation examined 
after 24 h at 37°C.  10 colonies from each variant of the three strains and of 
C375 and O16 were transferred from 7 to 10 times. 
resonance. After mild base hydrolysis of the K1-OAc  +  polysaccharide,  the aaC-NMR 
spectrum  was indistinguishable  from  that  of the K1-OAc-  polysaccharide,  establish- 
ing the presence  of O-acetylation  as  a  difference between  the two.  The  degree  of O- 
acetylation  (given  as  equivalents  of  O-acetyl  per  sialic  acid  residue)  is  readily 
established  by  comparative  integration  of the  NHC(O)CHn  and  OC(O)CHa  signals. 
These  values are given in Table  II. The  polysaccharide  appears  equally acetylated  at 
the  C9  and  C7  position,  as  approximately  one-half  of  each  of  the  C9  and  C7 
resonances are shifted downfield  by --3 ppm  and  the C8 resonance  is almost entirely 674  ESCHERICHIA  COLI K1-POLYSACCHARIDE  FORM  VARIATION 
l  j 
c  ,  13688 OAc+, buetreated, 
I  t  I  ,  I  ,  I  ,  I 
2OO  1GO  IO0  50  0 
FIG. 2.  High resolution laC (67.89 MHz)  NMR spectra of E. coli Kl-variant polysaccharides. A. 
Group  B  meningococal  polysaccharide.  B.  D699 (OAt-). C.  De-O-acetylated  D698. D.  D698 
(OAt+).  The  spectra  for  the  D699 (OAt-),  De-O-acetylated  D698 (OAt+),  and  group  B 
meningococcal polysaccharides are identical. The D698 (OAt+) spectrum differs from the latter 
three by the presence of O-aeetyl and the various spectral shifts induced by this moiety are described 
in Results. 
shifted upfield by -~3 ppm. The downfield shifts on C9 and C7  are results of direct 
substitution and the upfield shift on C8 is a  result of proximal substitution. The effect 
of C9 and C70-acetylation  is also seen in the splitting of the anomeric carbon signal 
(C9  105  ppm). 18C-NMR spectra of group B  meningococcus and the E.  coli Kl-form 
variant pair D698 (OAc +) and D699 (OAc-) are given in Fig. 2. The line broadening 
of the  K1-OAc+  polysaccharide  resonances,  in  addition  to  the  above  mentioned 
resonance shifts, is best explained by heterogeneity of the distribution of the O-acetyl 
within the NANA polymer. A comparable heterogeneity of O-acetyl moieties in group 
C  meningococeal polysaceharide, an a-2-9-NANA homopolymer, have been observed 
(26, 54). 
Serologic Properties.  It was not possible to prepare a  homogeneous OAc +  polysac- ORSKOV ET AL. 
TABLE II 




Variant  Sialic  Nucleic  Molecule 
Strain  Serotype  laG-NMR  Protein 
status  acid  acid  size 
Hestrin  (O-acetyl/ 
NANA) 
% wt/wt  I,  tM/mg  % wt/wt  % wt/wt  Kd 
D698  Ol :KI :H-  OAc +  80.2  2.7  0.85  0.1  0.5  0.44 
D699  O 1  :KI :H-  OAc-  86.4  0.6  0.0  0.2  0.4  0.44 
C94  O7:KI :H-  OAc +  94.0  4.3  0.31  0.3  0.4  0.39 
C94  OT:K 1  : H-  OAc-  82.0  ND*  0.0  0.3  0.2  0.41 
LH  O75:KI:H3  OAc+  90.0  3.4  0.67  0.1  0.6  0.36 
LH  (prep. 2)  OAc +  85.0  2.7  0.70  0.1  ND  0.3 I 
LH  O75: K 1  : H3  OAc-  76.0  ND  0,00  0.4  0.8  0.43 
C375  OI32:KI:H-  OAc+  92.2  2.5  0.22  0.1  0.3  0.43 
OI6  O 16:K 1  :H-  OAc-  94.1  ND  0.00  0. I  0.3  0.43 
E, coli KI-form variants, derived from the same parent, were selected on the basis of halo formation on antiserum agar. The O-acetyl 
determined by laC NMR, is expressed as O-acetyl equivalents per residue of NANA. 
* ND, not detectable. 
content, 
charide  because  of the  observations  cited  above.  A  similar  problem  in  obtaining 
homogeneous anti-K1 antibodies was encountered. Considering the 7-yr immm,iza- 
tion with formalinized organisms and the wide prevalence of E.  coli K1 strains, it is 
likely that horse 46 antisera is not an exclusive OAc- reagent (12,  19, 55). There was, 
however, no detectable O-acetyl in the O16 K1 and group B meningococcal polysac- 
charides. 
The effect of increasing K 1 polysaccharides D698 (OAc +), D699 (OAc-) and the 
stable O16  (OAc-)  concentrations upon the formation of antibody precipitate from 
horse 46 group B meningococcal globulin is shown in Fig. 3. Maximum precipitation 
occurred  at  lower  concentrations  of OAc-  polysaccharides.  However,  the  D698 
OAc +  polysaccharide, at about fivefold higher concentrations, precipitated a com- 
parable amount of antibody as the two OAc-  polysaccharides. At the equivalence 
zones  for each  antigen,  no  antibody was  detectable  in  the  supernates  using both 
variant polysaccharides as antigens. 
In  a  representative  double-immunodiffusion experiment,  horse  46  globulin was 
reacted with D698  (OAc +), D699 (OAc-)  and group B meningococcal polysaccha- 
rides  (Fig.  4).  A  single  identity line  was  observed  with  the  D699  and  group  B 
meningococcal polysaccharides.  In  contrast,  two  precipitin  lines, showing identity 
with the OAc- polysaccharides, were observed with D698  (OAc+). Not shown are 
the comparable results obtained in double-immunodiffusion experiments with rabbit 
and the burro antisera. Both burros yielded single precipitin lines with OAc-  and 
double  precipitin  lines with  OAc+  polysaccharides. All  lines showed  an  identity 
reaction. Some rabbits, injected with OAc +  organisms, produced antiserum reactive 
only with OAc +  polysaccharides. Other rabbits injected with OAc +  organisms and 
the rabbits  injected with OAc-  organisms showed the same reactivity as  the two 
burros and horse 46 (Table III). IEP showed that the single OAc- and double OAc + 
precipitin lines had identical rapid anodal mobility characteristic of K acidic capsular 
polysaccharides (11,  20, 48).  A  finer characterization of horse 46 K1  antibodies was 
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Fro.  3.  Quantitative precipitin analysis using equal volumes (2 ml) horse 46 group B meningococ- 
cal globulin and Kl-variant polysaceharides  of increasing  concentration. The reactants were mixed, 
incubated at 37°C for 1 h and 3 d at 4°C. The precipitates were removed by eentrifugation and the 
washed precipitates analysed for their antibody content (Materials and Methods). Excess antigen 
and antibody in the supernates were detected by CIE  using horse 46 group B meningococcal 
globulin for the K1 antigens and the K1 antigens for excess antibody. 
Flo. 4.  Double immunodiffusion  with horse 46 group B meningococcal  globulin (center well) and 
0.5 mg/ml polysaccharides. Wells 1 and 4 contain group B meningococcal  polysaccharide (FRII), 
wells 2 and 5 contain E. coli K1 D699 (OAt-), and wells 3 and 6 contain E. coh' K1 D698 (OAc+). 
with O16 (OAc-) and D698 (OAc +) polysaccharides. A precipitin spur extends from 
the O16 (OAc-) line (arrow 1) and another fine, difficult to see spur extends from the 
O16 (OAc-) to the D698 (OAc +)  (arrow 2). Consistent with the results obtained by 
double immunodiffusion and IEP, an additional precipitin line was formed between 
horse  46  antiserum  and  D698  (OAc+)  polysaccharide.  Not  shown  were  in  situ 
absorptions using tandem-crossed IEP with both variant polysaccharides. All precip- 
itin lines could be elevated and ultimately removed from the horse 46 globulin with 
either polysaecharide. 
Fig.  6  shows  the  difference  in  precipitin  patterns  when  K1  polysaccharides  of 
different  O-acetylation  are  reacted  with  group  B  meningococcal  serum.  D698 
(OAc+), with 85%  O-acetyl equivalents/NANA had two precipitin lines that  were ORSKOV  ET  AL.  677 
TABLE  III 
Specificity and Antibody Activity of Rabbit and Burros Injected with Escherichia coli K1  Variants Derived 
from the Same Parent Strain 
Animal number  Immunogen 
K1 capsular polysaccharide 
Group B Mening.  E. coli K1 D698 
(OAc-)  (OAc + ) 
Titer*  No. lines  Titer  No. lines 
Rabbits 
5626  EC30Ac-  0  --  0  -- 
5627  ....  l0  1  5  1 
5628  ....  0  --  0  -- 
5629  ....  1  1  0  -- 
5630  Ec30Ac +  0  --  0  -- 
5631  ....  0  --  20  2 
5632  ....  0  --  1.4  2 
5633  ....  0  --  0  -- 
5634  (294 OAc-  10  1  3.3  2 
5635  "  "  5  1  0  - 
5636  ....  3.3  1  1  1 
5637  ....  0  --  0  - 
5638  C94 OAc +  0  --  5  1 
5639  ....  0  --  5  2 
5640  ....  0  --  5  2 
5641  ....  0  --  5  1 
5642  D698 OAc +  0  --  10  1 
5643  ....  0  --  0  m 
5644  ....  0  --  20  1 
5645  ....  0  --  0  -- 
5647  D699 OAc-  0  --  0  -- 
5648  ....  2  1  l  1 
5649  0  --  0  -- 
Burros 
B 279  D698 OAc +  1  1  3.3  1 
B283  D699 OAc-  10  1  3.3  1 
* Reciprocal dilution yielding detectable precipitation with 0.1  mg polysaccharide/ml in CIE.  Antisera 
were diluted in saline and assayed immediately for precipitins by CIE as described in Methods. The 
number of distinct lines formed by the reaction mixtures is listed. 
widest  apart.  The  two  precipitin  lines  were  closest  with  C94  (OAc+)  with  31%  O- 
acetyl eq/NANA  and  the lines were of intermediate  distance  with  LH  (OAc +)  (70% 
O-acetyl/NANA). 
Neuraminidase  Sensitivity.  After  incubation  with  influenza  A2  virion,  rapid  degra- 
dation  into  sialic acid  monomers  was  observed  with  two  K10Ac-  preparations.  In 
contrast,  the K10Ac  +  preparation  showed  only slight degradation  with this enzyme. 
The  degree  of hydrolysis  of the  OAc-  preparation  by  the  influenza  virion  was  low, 
owing  to the inhibitory  effect ofthe  reaction product,  NANA.  The  OAc +  preparations 
were  also  resistant  to  C.  perfringens  neuraminidase  (Fig.  7).  It  was  not  possible  to 
demonstrate  directly  NANA  hydrolysis  of C.  perfringens  neuraminidase,  because  this 
enzyme  preparation  contained  4-6%  NANA  aldolase  activity  (38).  The  NANA 
released  by  the  C.  perfringens  enzyme  was  a  substrate  for  this  contaminant,  and 
therefore,  could  not  be  detected  by  the  colorimetric  reactions.  The  comparative 
susceptibility  of the K1  variants  to C. perfringens  neuraminidase  was measured  by two 678  ESCHERICHIA COLI KI-POLYSACCHARIDE  FORM VARIATION 
FIG. 5.  Tandem-crossed immunoelectrophoresis of E.  coli K1  capsular polysaccharides, O16 
(OAc-) in well A and D698 (OAc+) in well B, were reacted against horse 46 group  B meningococcal 
globulin. The anode is to the right in the first dimension electrophoresis and at the top in the second 
dimension electrophoresis. 
methods. First, the unreleased or polymeric NANA was measured using acid hydrolysis 
of the reaction mixture (36). Fig. 7 shows that only 12% of the NANA from the OAc + 
preparations were released. In contrast, 88% of the OAc- NANA were released after 
incubation  with  C.  perfringens  neuraminidase.  Second,  the  degradation  of the  K1 
polysaccharides  was  characterized  by  gel  filtration  through  Sepharose  4B  which 
revealed that only OAc- preparations were depolymerized by C. perfringens  neuram- 
inidase. 
Comparative  Immunogenicity.  23 Rabbits and 2 burros were immunized with OA + 
and OA-  variants derived from the same parents  (Table III). The bacterial suspen- 
sions used for injection contained a small amount of the other variant due to the low, 
but  constant,  rate  of  reversion  between  the  OAc+  and  OAc-  forms.  Rabbits 
immunized with OAc- organisms produced antibodies reactive with OAc- polysac- 
charides  (6/11).  Four of these animals injected with OAc- organisms also produced 
anti-K10Ac 4-  antibodies.  Injection of OAc 4-  strains induced OAc+  antibodies in 
8/12 rabbits.  None of the OAc +-injected rabbits produced detectable precipitins to 
OAc- polysaccharides. The geometric mean titer of OAc +  antisera, raised by OAc 4- 
organisms,  was  6.58  compared  to  3.86  for anti-OAc- antibodies  raised  by OAc- ~RSKOV  ET  AL.  679 
FIo.  6.  OAc+  K1 polysaccharides prepared from various E. coli form variant pairs of different O- 
acetyl content were reacted against horse 46 group B meningoeoccal globulin by crossed immunoe- 
lectrophoresis.  All  the OAc+  K1  polysaccharides showed  two  precipitation  lines.  The  distance 
between the two lines was related to their O-acetyl as measured by 13C NMR. D698 (OAt+), with 
85%  O-acetyl/NANA/residue was widest apart, C94  (OAt+)  with 31% was closest and LH with 
70% was intermediate. 
100 
LH OAc  -- 
80  ~  OAc -- 
20  /]  LH OAc + 
...................  i 
1  3  9  24 
INCUBATION  TIME  (hours) 
FIG.  7.  Hydrolysis of Escherichia  col," K1  form variant polysaccharides by C. perfringens  neuramlni- 
dase.  OAc+  and  OAc-  K1  polysaecharides were  reacted  with  C.  perfringens  neuraminidase as 
described in  Methods. The unreleased NANA was measured by the method of Warren  (37)  after 
acid-catalyzed hydrolysis. 
organisms.  Both burros made low levels of antibodies reactive with both Kl-variant 
polysaccharides. 
Discussion 
Variation among bacterial  structures,  not mediated by usual  genetic  mechanisms 
such  as  mutation  or the loss of chromosomal or extrachromosomal  DNA, has been 68O  ESCHERICHIA  COLI K1-POLYSACCHARIDE FORM VARIATION 
described in  Enterobacteriaceae (56-58).  Form variation of Salmonella  O antigens 
was  first  described by Kauffman as  an oscillating, serologically detectable, change 
between a  positive state in which a  certain determinant  is present, and  a  negative 
state in which it is absent (31). One such form variation is illustrated by antigen 122 
of group  B  Salmonella  (58).  The term,  form variation,  was  chosen  for E.  coli  K1 
polysaccharide because of its similarity to that observed in some somatic (O) antigens 
of Salmonella (20, 21, 31). The antigenic variation of the K 1 polysaccharide is a result 
of random O-acetylation of C7 and C9 as determined by chemical assay, IaC-NMR 
spectroscopy and antigenic analysis. The mechanism for this phenotypic change has 
not been identified but the theory that an unstable part of the DNA loop regulating 
biosynthesis or activity of a membrane transacetylase is related to this variation seems 
plausible and is subject to experimental verification (59). An antigenic specificity may 
be conferred by O-acetyl as has been shown  for abequose of antigen 5 of group B 
Salmonella (56, 58). 
The  Kl-form  variants  have  different  antigenic,  immunogenic,  and  biochemical 
properties. We have no clear idea of the selective force(s) regulating this variation. 
The OAc +  polysaccharide resists hydrolysis by neuraminidases, hence, this variant 
may favor survival of K1 organisms in the intestinal tract (60).  On the other hand, 
the  OAc+  K1  polysaccharide  is  more  immunogenic,  accordingly  host  immune 
mechanisms  may  favor  survival  of OAc-  organisms  (16).  The  finding  of  lytic 
bacteriophage specific for the K1  polysaccharide provides another variable to study 
the relation of O-acetylation and E. coli physiology (64). The relation of the O-acetyl 
moiety to the virulence of E. coli K 1 organisms has not been identified. The observation 
that most K1 isolates from CSF of newborns were of the OAc- form may be related 
to the practice of isolating K1  colonies from the group B meningococcal antiserum 
agar.  The  OAc-  form  variant  yields  a  much  more  distinct  and  intense  halo  of 
precipitation.  This property may have  favored their selection for further serologic 
analysis. Studies involving several laboratories to study the frequency of OAc +  and 
OAc-  variants among E.  coli  K1 isolates from healthy and diseased individuals are 
under way. 
Serological studies show two major antigenic determinants in the K 1-polysaccharide 
variants. One is a result of the OAc- polysaccharide. The other is probably a result 
of O-acetylation modifying the OAc- determinants. K1 polysaccharides derived from 
OAc +  strains contain at least two populations of molecules: one with O-acetylated 
and  non-O-acetylated  determinants  and  another,  in  lesser  amounts,  that  is  only 
OAc-. The O-acetyl itself is not an antigen. The observation that either K1 variant 
can remove all OAc-  antibodies from horse 46 and rabbit OAc- antisera indicates 
that  O-acetyl  groups  are  only  modifying OAc-  molecules.  The  minor  antigenic 
determinants, revealed by the fine spurs of precipitation in the tandem-crossed iep, 
may be explained by the random O-acetylation at C7 and C9. The O-acetyl moiety, 
does however, confer immunogenic specificity to the K 1 antigens when whole bacteria 
are injected. Rabbits injected with K1-OAc+  strains produced mostly OAc+  anti- 
bodies. In contrast, OAc-  strains  induced antibodies in some rabbits reactive with 
both variants. The level of these OAc- antibodies was lower than the OAc +  injected 
rabbits. No conclusions regarding species reactivity can yet be drawn because the two 
burros produced cross-reactive antibodies.  Studies in volunteers, using purified K1- 
variant polysaccharides, are planned to characterize their comparative immunogen- 
icity and specificity to E.  coli K1 and group B meningococci. (~RSKOV ET AL.  681 
Three explanations for the different O-acetyl contents in the OAc +  preparations 
from the four E.  coli strains can be forwarded. The first, is that  the reversion rates 
from OAc +  to OAc- are related to their O°acetyl content. The low O-acetyl content 
(0.22/~M/mg) of C375 K 1 polysaccharide, derived from a nonreverting OAc +  strain, 
rules against this possibility. The second, is that the extent of acetylation is unique for 
each strain. Our preliminary evidence favors this possibility. Third, is that the culture 
conditions, as has been shown for group C  meningococcal polysaccharide (26), may 
influence the extent of O°acetylation for each strain.  Presently, we are not  able to 
define the extent to which each variable operates within a given strain. O-acetylation 
of polysaccharides, including group C  meningococcal polysaccharide, another sialic 
homopolymer, occurs after biosynthesis of the  polymeric NANA  (62,  63).  Further 
studies of this process are in progress to characterize more accurately these aspects of 
Kl-form variation. 
Form variation may have been the cause of problems in identifying E.  coli disease 
isolates  (22,  65,  66,  68,  69).  Several authors  have commented  about  the  different 
serologic reactivity of strains designated K 1 by conventional typing antisera. Exami- 
nation  of E.  coli  sent  to  the  Central  Public  Health  Laboratories  of the  United 
Kingdom at Colindale revealed that ---50% of CSF isolates from newborns and young 
infants were Kl-containing strains, as adjuged by halo formation on meningococcal 
group B antiserum agar. With rabbit E. coli typing antisera, an additional 22 isolates 
were identified as K 1. The authors concluded that halo reaction with horse group B 
meningococcal antiserum agar was a more reliable Kl-typing assay than agglutination 
with rabbit E.  coli typing antisera (22).  Further investigation of E.  coli isolates using 
this new information regarding the Kl-form variation is indicated. 
The neuraminidase susceptibility of both the E. coli K1 and group B meningococcal 
capsular polysaccharides may be an  important  clue to their unusual  immunologic 
behavior. These two polysaccharides, confering virulence to two bacterial species: are 
unusual compared to other bacterial capsules. As purified polysaccharides, both fail 
to induce detectable serum  antibodies  in  most  adult  humans  (29,  30).  Even when 
injected as whole encapsulated bacteria, the capsules of both E. coli K1 and group B 
meningococcus are poor immunogens (20, 28, 29, 47). One obvious difference between 
E.  coli  K1  and meningococcus group B polysaccharide compared to other bacterial 
capsular polysaccharides is their susceptibility to rapid enzymatic depolymerization 
by neuraminidase (27).  This enzyme is present as an extracellular product of several 
intestinal bacteria and in mammalian cells (60). Thus, the discovery of the neuramin- 
idase-resistant K1 capsular polysaccharide may provide an effective vaccine for these 
two organisms.  Studies using whole encapsulated bacteria suggest  that the OAc+ 
variant  may  be  more  immunogenic.  The  presence  of O-acetyl  moieties  has  been 
related to the comparative immunogencity of  other bacterial capsular polysaccharides. 
For pneumococcal type  1,  O-acetyl is  directly related  to immunogenicity (67).  In 
contrast, the O-acetyl negative group C meningococcal polysaccharide variant is more 
immunogenic in young adults than the more prevalent O-acetyl positive capsule (66, 
68). These findings suggest that the O-acetyl moiety, per se, is not directly related to 
immunogenicity.  Rather,  the  differences  in  overall  polysaccharide  structure  are 
involved. 
Summary 
The chemical basis for the alternating antigenic change called form variation noted 
for the  Escherichia  coli  K1-capsular polysaccharide has  been  shown  by lac  nuclear 682  ESCHERICHIA  COLI K1-POLYSACCHARIDE  FORM VARIATION 
magnetic resonance to be a  result of random O-acetylation of C7 and C9 carbons of 
the a-2-8-1inked sialic acid homopolymer. A  serologic method  (antiserum  agar)  was 
developed  to  identify  and  isolate  the  form variants.  The  O-acetyl  positive  and  O- 
acetyl negative K1 polysaccharides had unique biochemical and immunologic prop- 
erties.  The O-acetyl-positive variants resisted neuraminidase hydrolysis in contrast to 
the  susceptibility  of the  O-acetyl  negative  variant  to  this  enzyme.  In  addition,  O- 
acetylation altered the antigenicity of the O-acetyl polysaccharides. When injected as 
whole organisms, O-acetyl positive organisms produced anti-K1  antibodies in rabbits 
specific for this  polysaccharide variant.  O-acetyl negative organisms were compara- 
tively  less  immunogenic;  however,  antibodies  induced  by  these  organisms  reacted 
with both K1 polysaccharide variants. Burros, injected with either variant, produced 
antibodies reactive with both K1 polysaccharides. 
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